Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies

March 2024 in “ Current issues in molecular biology ”

Isabella J. Tan, Alicia Podwojniak, Ameet Parikh, Bernard A. Cohen

alopecia areata psoriasis hidradenitis suppurativa TNF-α IL-1β lipocalin-2 JAK inhibitors adalimumab AI nanotechnology multi-omics AA HS tumor necrosis factor-alpha interleukin-1 beta Janus kinase inhibitors Humira artificial intelligence

TLDR Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The review "Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies" highlights the transformative impact of molecular biomarkers in diagnosing, staging, and treating dermatological conditions such as alopecia areata (AA), psoriasis, and hidradenitis suppurativa (HS). Key biomarkers like TNF-α, IL-1β, and lipocalin-2 inform targeted therapies, including JAK inhibitors for AA and adalimumab for HS. Despite some biomarkers being more scientifically valuable than clinically practical, advancements in AI, nanotechnology, and multi-omics hold promise for enhancing personalized dermatological care, ultimately improving patient outcomes and treatment efficacy.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research The Roles of WNT Signaling Pathways in Skin Development and Mechanical-Stretch-Induced Skin Regeneration

2 citations , November 2023 in “Biomolecules”

WNT signaling is crucial for skin development and healing.

research Biomarkers in Alopecia Areata: A Systematic Review and Meta-Analysis

4 citations , April 2023 in “Autoimmunity reviews”

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

research Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial

227 citations , April 2023 in “The Lancet”

research The Efficacy and Safety of JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis of Prospective Studies

37 citations , August 2022 in “Frontiers in pharmacology”

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

research Intralesional Vitamin D3 in Treatment of Alopecia Areata: A Randomized Controlled Clinical Trial

7 citations , February 2022 in “Journal of Cosmetic Dermatology”

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

research Ritlecitinib And Brepocitinib Demonstrate Significant Improvement In Scalp Alopecia Areata Biomarkers

36 citations , December 2021 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology”

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Efficacy and Safety of the Oral Janus Kinase Inhibitor Baricitinib in the Treatment of Adults with Alopecia Areata: Phase 2 Results from a Randomized Controlled Study

research Efficacy and Safety of the Oral Janus Kinase Inhibitor Baricitinib in the Treatment of Adults with Alopecia Areata: Phase 2 Results from a Randomized Controlled Study

66 citations , June 2021 in “Journal of The American Academy of Dermatology”

Baricitinib is effective and safe for treating severe alopecia areata.

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

research An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

130 citations , February 2018 in “Journal of Investigative Dermatology”

Tofacitinib may help treat severe hair loss, but more research is needed.

research Macrophages Induce AKT/β-Catenin-Dependent Lgr5+ Stem Cell Activation and Hair Follicle Regeneration Through TNF

117 citations , March 2017 in “Nature Communications”

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

research Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata

196 citations , September 2016 in “JCI insight”

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Compartmentalized Epidermal Activation of β-Catenin Differentially Affects Lineage Reprogramming and Underlies Tumor Heterogeneity

research Compartmentalized Epidermal Activation of β-Catenin Differentially Affects Lineage Reprogramming and Underlies Tumor Heterogeneity

54 citations , January 2016 in “Cell reports”

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Similar Research

5 / 1000+ results

research Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders

January 2025 in “International Journal of Molecular Sciences”

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

research Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection

February 2024 in “International journal of molecular sciences”

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

A Systematic Review of Tumor Necrosis Factor-α Blockers, Anti-Interleukins, and Small Molecule Inhibitors for Dissecting Cellulitis of the Scalp Treatment

research A Systematic Review of Tumor Necrosis Factor-α Blockers, Anti-Interleukins, and Small Molecule Inhibitors for Dissecting Cellulitis of the Scalp Treatment

May 2025 in “Orphanet Journal of Rare Diseases”

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

research PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds

9 citations , June 2023 in “Cells”

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

research Metabolic Syndrome and Dermatological Diseases: Association and Treatment

10 citations , May 2025 in “Nutrition & Metabolism”

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.